JPRN-jRCT2080220988未知3 期
Randomized phase III study of S-1 plus oxaliplatin compared with S-1 plus cisplatin as first-line therapy for advanced or recurrent gastric cancer
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Gastric cancer confirmed by histological diagnosis or cytologic diagnosis
- •-Advanced/Recurrent gastric cancer
- •-Not pretreated with chemotherapy drugs, immunotherapeutic drugs, or radiation therapy
- •-ECOG Performance Status 0 to 2
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Phase III Adjuvant Chemotherapy of S-1 plus Oxaliplatin for Colorecrtal Cancer (ACTS-CC 02)JPRN-jRCT1080221040Taiho Pharmaceutical Co., Ltd.1,200
未知
3 期
A Randomized Phase III Trial of SOX/Bevacizumab versus FOLFOX/Bevacizmab in Treating Patients with Metastatic Colorectal Cancer (SOFT).JPRN-jRCT1080220674Taiho Pharmaceutical Co., Ltd.500
已完成
1 期
A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal CarcinomaColorectal CancerJPRN-UMIN000017450Japan Clinical Cancer Research Organization45
未知
3 期
Randomized trial of oxaliplatin plus S-1 (SOX) versus S-1 alone in patients with gemcitabine-refractory pancreatic cancerJPRN-jRCT2080220660Yakult Honsha Co.,Ltd.240
已完成
2 期
Phase II study of S-1 plus oxaliplatin (130 mg/m2, every 3 weeks) for advanced gastric cancerJPRN-UMIN000016973Shizuoka Cancer Center25